Biogenesis of the immune synapse at the interface between antigenpresenting cells and T cells assembles and organizes a large number of membrane proteins required for effective signaling through the T-cell receptor. We showed previously that the intraflagellar transport protein 20 (IFT20), a component of the intraflagellar transport system, controls polarized traffic during immune synapse assembly. To investigate the role of IFT20 in primary CD4
Biogenesis of the immune synapse at the interface between antigenpresenting cells and T cells assembles and organizes a large number of membrane proteins required for effective signaling through the T-cell receptor. We showed previously that the intraflagellar transport protein 20 (IFT20), a component of the intraflagellar transport system, controls polarized traffic during immune synapse assembly. To investigate the role of IFT20 in primary CD4
+ T cells in vitro and in vivo, we generated mice bearing a conditional defect of IFT20 expression in T cells. We show that in the absence of IFT20, although cell spreading and the polarization of the centrosome were unaffected, T-cell receptor (TCR)-mediated signaling and recruitment of the signaling adaptor LAT (linker for activation of T cells) at the immune synapse were reduced. As a consequence, CD4
+ T-cell activation and proliferation were also defective. In vivo, conditional IFT20-deficient mice failed to mount effective antigen-specific T-cell responses, and their T cells failed to induce colitis after adoptive transfer to Rag −/− mice. IFT20 is therefore required for the delivery of the intracellular pool of LAT to the immune synapse in naive primary T lymphocytes and for effective T-cell responses in vivo. V esicular traffic has emerged as a central player in the assembly and function of the immune synapse (IS), the specialized interface that forms at the T-cell membrane on contact with an antigen-presenting cell (APC) bearing cognate peptide-MHC complexes. Indeed, polarized recycling of several receptors (1, 2) , including the T-cell receptor (TCR) (3) , has been shown to control the clustering of these receptors at the synaptic zone and to sustain signaling initiated by their engagement. It is now well established that vesicular traffic to the IS is coopted not only by receptors but also by membrane-associated signaling mediators that are required for signal initiation and amplification, the most prominent being the kinase Lck and the adaptor LAT (linker for activation of T cells) (4, 5) . These molecules are carried to the IS by recycling endosomes that move along microtubular tracks toward the centrosome, which polarizes just below the IS on contact with the cognate APC (6) .
We have recently provided evidence that the intraflagellar transport protein 20 (IFT20) (7) and other components of the intraflagellar transport (IFT) system, which regulates the assembly of the primary cilium (8) , act as unconventional players in IS assembly by selectively controlling the polarized traffic of recycling TCRs and other recycling receptors, such as the transferrin receptor (TfR) (9, 10) . We investigate here the role of IFT20 in T-cell activation, using a conditional knockout mouse carrying a null IFT20 allele in T cells. We show that IFT20 is required for TCR signaling, IS formation, and recruitment to the TCR activation sites of vesicular LAT downstream of centrosome polarization. These defects in TCR-induced signaling of IFT20-deficient T lymphocytes translate to an inability to mount an antigen-specific T-cell response both ex vivo and in vivo. We also provide evidence of the physiological relevance of these findings by showing that IFT20 deficiency affects disease severity and outcome in a mouse model of CD4
+ T-cell-driven colitis.
Results and Discussion IFT20 Controls TCR-Induced Signaling. We previously reported that IFT20 regulates vesicular trafficking to the IS in human T cells (9, 10) . To achieve insights into the role of IFT20 in T cells in vivo, we crossed transgenic mice expressing the Cre recombinase under the control of a CD4 minigene with mice in which the Ift20 locus was flanked by loxP sites upstream of exon 2 and downstream of exon 3 (11) (Fig. 1A ). This strategy led to a complete loss of IFT20 expression in CD4 + T cells (Fig. 1B) . The percentages and numbers of DP and CD4
+ or CD8 + T cells in the thymus were normal ( Fig. 1C and Fig. S1A ), suggesting there was no gross perturbation in T-cell development, in agreement with a recent report (12) . The percentages and numbers of CD4 + /TCRβ + T cells in blood, lymph nodes (LN), spleen, and bone marrow were also normal, showing that IFT20 deficiency affects neither CD4 + T-cell egress from the thymus nor their homeostasis in the periphery (Fig. 1C and Fig. S1A ). Finally, the percentages and numbers of CD62L and IFT20 −/− CD4 + T cells purified from bone marrow, spleen, and blood ( Fig. 1C and Fig. S1B ), suggesting peripheral T-cell differentiation was normal.
Significance
The immune synapse (IS), the site of cell-cell contact between T cells and antigen-presenting cells, plays a crucial role in the mounting of an immune response. Although IFT20 (intraflagellar transport protein 20), a component of the intraflagellar transport system, regulates polarized traffic to the IS, its role in T-cell activation in vivo is unknown. Here we show that in the absence of IFT20, T-cell receptor (TCR)-mediated signaling and recruitment of the signaling adaptor LAT to the immune synapse are impaired, leading to defective CD4 + T-cell activation and proliferation. IFT20-defective mice fail to mount effective antigen-specific T-cell responses, and their T cells do not induce disease in a T-cell-adoptive transfer model of colitis. 
However, stimulation of IFT20-deficient CD4
+ T cells by CD3 + CD28-specific mAbs led to a reduced induction of phosphorylation of PLC-γ1 (phospholipase C γ), Vav, and the MAPKs (mitogen-activated protein kinase) Erk1/2 (extracellular signal-regulated kinase) compared with control littermate T cells (Fig. 1D) . Similarly, TCR-induced signaling, namely, phosphorylation of Zap70, Vav, and LAT, was found to be impaired in Jurkat T cells silenced for IFT20 ( Fig. 2A) . These results confirm and extend our previous results obtained in human primary T cells, as well as Jurkat T cells (9) , by showing that IFT20 is required for early signaling in primary murine T lymphocytes. The defect in TCR triggering reported here may be attributed to the role of IFT20 in endosome recycling. Indeed, IFT20 deficiency has been shown to affect TCR and TfR recycling (9, 10) , and might similarly affect recycling of signaling molecules that control early TCR triggering.
IFT20 Controls the Recruitment of LAT to TCR Activation Sites. Given the observed impairment of TCR-mediated signaling, we next analyzed the recruitment and activation of Zap70, a tyrosine kinase essential for TCR signaling (13), at the IS of IFT20-deficient T cells. For these experiments, we used T cells purified from Ift20 fl/fl CD4-Cre mice crossed with OTI or OTII mice, which express a transgenic TCR specific for peptides derived from hen ovalbumin (OVA) in the context of H2K b or I-A b , respectively. Phospho-Zap70 (pZap70; phosphorylated-ζ-chain-associated protein kinase) recruitment to the IS was analyzed by confocal microscopy in CD4
+ T lymphocytes incubated with LPS-matured bone marrow-derived dendritic cells (BMDC) pulsed with the specific OVA peptides. The enrichment in pZap70 at the T-cell:APC contact area was reduced for both OTI/IFT20
−/− and OTII/IFT20 −/− T cells (Fig. 3A) , (mean ± SEM) (n ≥ 3). Statistical significance was calculated using a ratio paired t test. *P < 0.05; **P < 0.01. showing that IFT20 expression controls antigen-specific signaling at the IS. Similar results were obtained when pZap70 and pVav recruitment to the IS was analyzed on Jurkat IFT20KD cells (Fig. 2B) .
IS formation is accompanied by T-cell spreading resulting from actin remodeling (14) . To analyze this event, IFT20
−/− CD4 + T cells were incubated on coverslips coated with CD3 + CD28-activating mAbs or poly-L-lysine as control. F-actin was labeled with fluorescent phalloidin, and the cell area and perimeter were measured using Image J software. Activation by CD3 + CD28-specific mAbs induced spreading of T cells compared with poly-L-lysine. No defect in spreading was observed in IFT20-deficient CD4 + T cells (Fig. 3B ). LAT, a key adaptor protein involved in T-cell development and activation (15, 16) , has been shown to be present not only at the plasma membrane but also in subsynaptic vesicles that are rapidly recruited to activation sites in T lymphocytes (17) (18) (19) . LAT has also been shown to partially colocalize with the TfR, strongly suggesting it undergoes recycling (5). Given the role of IFT20 in TfR recycling (10), we studied the relative localization of IFT20 and LAT. Confocal imaging of Jurkat cells costained for LAT and IFT20 showed a significant colocalization of IFT20 with the vesicular pool of LAT (Fig. 2C) , which decreased after IS assembly, raising the possibility that IFT20 may be involved not only in TCR and transferrin receptor recycling (9, 10) but also in the traffic of vesicular LAT. To measure LAT recruitment, we incubated CD4 + T cells on coverslips coated with CD3 + CD28-activating mAbs, or poly-L-lysine as control, and performed total internal reflection fluorescence microscopy (TIRFM) on cells fixed and labeled with anti-LAT Abs, as previously described (19) . We observed a significant reduction in LAT recruitment to the TCR activation sites in IFT20
−/− CD4 + T cells, as shown by the lower density of LAT microclusters in the evanescent field (Fig. 3C) . This was not a result of defective expression of CD3 or CD28 by these cells, as assessed by flow cytometry (Fig. S1C) . Recruitment of the intracellular pool of LAT, which is triggered by the TCR and requires several signaling mediators, including LAT itself (5) , is controlled by centrosome polarization (20) . We measured the polarization of the centrosome toward the coverslips in wild-type and IFT20
−/− CD4 + T cells in the same experimental setting used for the analysis of LAT recruitment. No defect in centrosome polarization to the IS was observed in IFT20 −/− CD4 + T cells (Fig. 3D ), similar to our previous observation on human T cells (7) . This indicates that the signals triggered by the TCR in IFT20 −/− T cells, although less robust than the signals triggered in wild-type T cells (Fig.  1D) , are sufficient to promote centrosome translocation.
Of note, when the recruitment of LAT was quantified on confocal orthogonal images of the same slides used for TIRFM, no defect of polarization of LAT in the third of the cell nearest to the activating slide was observed in the IFT20 −/− CD4 + T cells (Fig. 3E) . Confocal imaging of IFT20-depleted Jurkat cells conjugated to staphylococcal enterotoxin E (SEE)-pulsed Raji cells showed that LAT (which, as a result of the resolution limits of this type of analysis, was likely to include both plasma membrane LAT and subsynaptic LAT + vesicles) was normally mobilized to the IS (Fig. 2D) . However, similar to mouse primary IFT20 −/− T cells, recruitment of LAT measured by TIRFM was decreased in IFT20-depleted Jurkat cells activated on slides coated with anti-CD3+CD28 Abs (Fig. 2E ). Taken together with the colocalization of IFT20 with vesicular LAT (Fig. 2C) , these results suggest that IFT20 regulates the last step of traffic of the vesicular pool of LAT that is normally polarized in IFT20-deficient T cells but does not reach or does not dock to the plasma membrane in the synaptic zone. Collectively, these results show that IFT20 acts as a central regulator of IS formation in primary CD4 + T cells by affecting essential events triggered by the TCR downstream of centrosome polarization, which can be accounted for not only by the defect in polarized TCR recycling reported previously (9, 10) but also by a defect in the traffic of vesicular LAT to the TCR activation sites.
IFT20 Controls ex Vivo Activation of T Lymphocytes. To next address the potential role of IFT20 in T-cell activation, CD4
+ T cells were purified from spleens and LNs and activated ex vivo, using different concentrations of CD3 + CD28-specific mAbs.
Expression of CD25 (Fig. 4A), proliferation (Fig. 4B) , and IFNγ production in the supernant (Fig. 4C) were reduced in IFT20
−/− CD4 + T cells compared with their wild-type counterparts, demonstrating that IFT20 expression is required for efficient activation of CD4 + T cells.
IFT20 Controls T Cell Functions in Vivo.
To test whether IFT20 controls TCR-induced T-cell activation in vivo, we first checked the T-cell response to an antigenic challenge. Lethally irradiated WT CD45.1 C57BL6 mice were reconstituted with bone marrow from CD45.2 Ift20 fl/fl CD4-Cre mice and Ift20 fl/fl controls (Fig.  5A) . Reconstitution of the T-cell compartment was comparable in chimeras generated with bone marrows from Ift20 fl/fl CD4-Cre and from Ift20 fl/fl littermate controls (Fig. 5B) . The mouse chimeras were immunized with OVA in complete Freund adjuvant, and 10 days after immunization, splenocytes were restimulated in vitro in the presence of OVA. Concentrations of cytokines present in the supernatants were measured 24 h later. Production of all cytokines tested (IL-17A, IFNγ, IL-4, TNF-α, and IL-2) was reduced in IFT20
−/− CD4 + T lymphocytes (Fig. 5C ). The impairment in IL-17A production by IFT20
−/− CD4 + T lymphocytes after in vitro restimulation with phorbol myristate acetate (PMA)+ionomycin or OVA was confirmed by intracellular staining (Fig. 5D) . These results show that expression of IFT20 by T cells is required for mounting a CD4
+ T-cell response after immunization.
To further analyze the role of IFT20 in T-cell activation, we used a T-cell-induced model of colitis. Naive CD4 + T cells purified from Ift20 fl/fl CD4-Cre mice and Ift20 fl/fl control littermates were transferred into C57BL6 Rag2 −/− mice. In this model, the T-cell transfer in immunodeficient mice induces a chronic colitis (21) . Because IL-17A was shown to be critical for T-cellmediated colitis (22) , mice were killed and CD4
+ T lymphocytes were purified from mesenteric LNs and activated with PMA+ionomycin to reveal their ability to produce IL-17A. The percentages of IL-17A + CD4 + T cells were lower in LNs from Ift20 fl/fl CD4-Cre mice compared with Ift20 fl/fl control littermates (Fig. 5E) . To appreciate the intestinal inflammation in the model, we measured the length of the colon. Colons from Rag2 −/− mice reconstituted with CD4 + T cells from control mice were significantly shorter than colons from Rag2 −/− recipient mice (Fig. 5E ). In contrast, colons from Rag2 −/− mice reconstituted with IFT20-deficient CD4
+ T cells did not show any significant modification of their length (Fig. 5E) . Finally, survival of the mice transferred with IFT20
−/− CD4 + T cells was not altered compared with that of control Rag2 −/− mice, whereas under the same conditions, the transfer of wild-type CD4 + T cells resulted in premature death of the mice or their being killed because of a weight loss of more than 20% of their initial body weight (Fig. 5E) . Collectively, these results show that IFT20
−/− CD4 + T cells have a strongly reduced pathogenicity, which is most probably a result of their reduced production of IL-17A, and possibly other proinflammatory cytokines. Interestingly, a recent report showed that ift20 deletion in CD4 T cells has only mild effects on the development of collagen-induced arthritis (12) , another T-cellrelated autoimmune disorder. Although the pattern of cytokine production was not investigated in that report, the effect of IFT20 deficiency on the development of pathogenic Th17 cells may have been underestimated in this experimental model, which involves the use of a potent adjuvant.
The data presented in this report extend and validate in vivo the role that IFT20 plays in IS assembly by regulating the traffic to the T-cell:APC interface not only of endosome-associated TCRs (9) but also of the endosomal pool of LAT, which acts as a scaffold for the assembly of multimolecular complexes that amplify TCR-generated signals. LAT is present both at the plasma membrane and in intracellular pools, which are recruited to the TCR activation sites (5, 17-19 ). Both pools have been shown to (1 μg/mL) mAbs (Left) or the indicated concentrations of α-CD3 and α-CD28 mAbs (Right). Cell proliferation (B) and IFNγ expression (C) were analyzed after 72 h of culture in the presence or absence of α-CD3 (10 μg/mL) and α-CD28 (1 μg/mL) mAbs (Left) or the indicated concentrations of α-CD3 and α-CD28 mAbs (Right). Error bars represent SEM (n = 3). Statistical significance was calculated using Student's t test. *P < 0.05; ***P < 0.005; ****<0.001.
play a role in T-cell activation (18, 19, 23, 24) . We show here that LAT fails to reach this membrane-proximal location in IFT20-deficient T cells (Figs. 2E and 3C) despite polarization of the centrosome (Fig. 3D) . However, LAT-dependent signaling is not completely abolished, suggesting the plasma membrane pool of LAT can still signal, but the subsynaptic vesicular pool cannot. It is worth noting that although partial, the signaling defect induces an important functional T-cell defect in vivo. Indeed, IFT20 deficiency results in a defect in the production of all the cytokines tested, including Th1, Th2, and Th17 cytokines. This result suggests the T-cell differentiation defects observed in IFT20 fl/fl /CD4 Cre mice are the consequence of the impaired ability of CD4 + T cells to become activated in response to TCR signaling, rather than of a selective defect in their differentiation. Although we favor the explanation that the defect in TCR signaling in IFT20 −/− T cells causes these defects in the biological response, we cannot at this stage rule out that IFT20 is implicated in the regulation of other pathways that control cytokine production. Moreover, it is possible that we underestimated the TCR signaling defect in our in vitro experiments where T lymphocytes are activated with high concentrations of anti-CD3 + CD28 Abs. In in vivo conditions, triggering of the TCR is likely to be much lower, thus allowing us to better reveal the functional outcome of IFT20 deficiency.
In conclusion, the results presented here show that, in primary mouse CD4 + T lymphocytes, IFT20 expression is required for TCR-induced signaling, recruitment of vesicular LAT to the TCR activation sites, and CD4
+ T-cell function in vivo. IFT20 is a component of the IFT system that controls the assembly of the primary cilium (8) . Based on our finding that a number of components that regulate this process are implicated in vesicular traffic to the IS in T cells (9, 10, 25, 26) , studying the pathways that control ciliogenesis should provide new molecules implicated in IS assembly and function.
Materials and Methods
Mice, Cells, Reagents, and Antibodies. Mice with T-cell-specific deletion of IFT20 were generated by crossing Ift20 fl/fl mice (11) with CD4-Cre mice. OTI and OTII mice were crossed to Ift20 fl/fl CD4-cre mice to obtain Ift20 fl/fl CD4-Cre OTI and Ift20 fl/fl CD4-Cre OTII mice, respectively. Further details are provided in the SI Materials and Methods.
Purification of naive CD4 + T cells from LNs and spleens was carried out as detailed in the SI Materials and Methods. BMDC were differentiated as described previously (27) . Details on the activation of BMDC, loading with either class I (OVA 257-264 ) or class II (OVA 323-339 ) peptide and incubation with OTI and OTII cells, respectively, are provided in the SI Materials and Methods. Cell lines include Jurkat T cells and Raji B cells. Stable IFT20 knock-down Jurkat cells (IFT20 KD; ∼70% depletion) were previously described (9). reconstituted with IFT20 +/+ (blue solid line) or IFT20 −/− (red solid line) BM. Data compiled from two experiments (n = 14 mice per group). *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001. Statistical significance was calculated using Student's t test (C and D) or one-way ANOVA (E).
